📰 Dose Exploration News

Dose Exploration News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dose Exploration. Real-time updates on events, politics, business and more.

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

May 25, 2024

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...

Czech Republic United States Parag Mahanti David Soergel Prnewswire Novartis Marianne Silkj

Source: prnewswire.com

Novartis Pharma AG: Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo

May 25, 2024

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2

United States Czech Republic Imke Kappes Marlena Abdinoor David Soergel Michael Meo

Source: finanznachrichten.de

4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights

May 10, 2023

Presented positive interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial for wet age-related macular degeneration at the 2023 ARVO Annual MeetingOn track for completion of enrollment... | May 10, 2023

David Kirn Julian Pei Katherine Smith Exchange Commission D Molecular Therapeutics Inc Corporate Communications

Source: marketscreener.com

FDA Panel Puts PI3K Inhibitors for Blood Cancers on Notice

April 22, 2022

With concerning survival, toxicity data, ODAC calls for randomized trials to support approvals

New York United States North Carolina Nicole Gormley Jorge Garcia Copanlisib Aliqopa

Source: medpagetoday.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation